Publications by authors named "Danielle Enserro"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12,072

Total Likes

183

Extended Reach

74,781

Social Features

10
T
Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.
Connie W Tsao, Asya Lyass, Danielle Enserro, Martin G Larson, Jennifer E Ho, Jorge R Kizer, John S Gottdiener, Bruce M Psaty, Ramachandran S Vasan

August 2018

Videos about Article: user user

2 2 8 2

View All Article and Social Media Activity
P
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.
Koji Matsuo, Danielle M Enserro, Jason D Wright, Lynda D Roman, Matthew A Powell

Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the Estimation of Prediction Increment Measures in Logistic and Survival Analysis.
Danielle M Enserro, Austin Miller

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Daniela E Matei, Danielle M Enserro, Marcus E Randall, David Mutch, William Small

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials.
Gina L Mazza, Eva Culakova, Danielle M Enserro, James J Dignam, Joseph M Unger

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to adjust for multiplicity in cancer clinical trials.
Joseph M Unger, Gina L Mazza, Mohamed I Elsaid, Fenhai Duan, Emily V Dressler, Danielle M Enserro

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges to and considerations of designing cancer prevention trials.
Danielle M Enserro, Heather J Gunn, Mohamed I Elsaid, Fenghai Duan, Stephanie L Pugh

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements, Danielle Enserro, Kyle C Strickland, Rebecca Previs, Daniela Matei

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Lilian T Gien, Danielle M Enserro, Matthew S Block, Steven Waggoner, Linda R Duska

Gynecol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.
Ann H Klopp, Danielle Enserro, Matthew Powell, Marcus Randall, Julian C Schink

J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
Ramachandran S Vasan, Danielle M Enserro, Vanessa Xanthakis, Alexa S Beiser, Sudha Seshadri

Circulation· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Nefertiti C duPont, Danielle Enserro, Mark F Brady, Katherine Moxley, Joan L Walker

Gynecol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missing repeated measures data in clinical trials.
Stephanie L Pugh, Paul D Brown, Danielle Enserro

Neurooncol Pract· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
Ramachandran S Vasan, Danielle M Enserro, Alexa S Beiser, Vanessa Xanthakis

J Am Coll Cardiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Megan E Buechel, Danielle Enserro, Robert A Burger, Mark F Brady, Katrina Wade

Gynecol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
Sandra Russo, Joan L Walker, Jay W Carlson, Jeanne Carter, Leigh C Ward, Danielle Enserro

Gynecol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Diane M Da Silva, Danielle M Enserro, Jyoti S Mayadev, Joseph G Skeate, Koji Matsuo

Clin Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course after a first episode of heart failure: insights from the Framingham Heart Study.
Raghava S Velagaleti, Martin G Larson, Danielle Enserro, Rebecca J Song, Ramachandran S Vasan

Eur J Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer.
Jyoti S Mayadev, Danielle Enserro, Yvonne G Lin, Diane M Da Silva, Heather A Lankes

JAMA Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
Robert L Coleman, Nick M Spirtos, Danielle Enserro, Thomas J Herzog, Paul Sabbatini

N Engl J Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
Danielle M Enserro, Olga V Demler, Michael J Pencina, Ralph B D'Agostino

Stat Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher

J Clin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recontact practices of cancer genetic counselors and an exploration of professional, legal, and ethical duty.
Amy Mueller, Emily Dalton, Danielle Enserro, Catharine Wang, Maureen Flynn

J Genet Couns· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study.
Nick M Spirtos, Danielle Enserro, Howard D Homesley, Susan K Gibbons, David Cella

Gynecol Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to F. Tomao et al.
Martee L Hensley, Danielle Enserro, David S Miller

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis